Click on the title to view the full review or protocol

Log on to The Cochrane Library to read protocols and full reviews. (click here for search tip)

[R] Cochrane review

1. Aripiprazole for psychosis-induced aggression or agitation  [P]
2. Interventions for psychotic symptoms concomitant with epilepsy  [R]
3. Intravenous immunoglobulins for epilepsy  [P]
4. Lamotrigine add-on for drug-resistant partial epilepsy  [R]

1. No reviews currently available for this topic

1. Advance treatment directives for people with severe mental illness  [R]
2. Antiglucocorticoid treatments for mood disorders [R]
3. Chlorpromazine for psychosis induced aggression or agitation  [P]
4. Exercise in prevention and treatment of anxiety and depression among children and young people  [R]
5. Exercise to improve self-esteem in children and young people  [R]  [S] 
6. Haloperidol plus promethazine for psychosis-induced aggression  [P]
7. Intensive Case Management for severe mental illness  [P]
8. Interventions for mood and anxiety disorders, and self harm in young offenders  [P]
9. Lithium for maintenance treatment of mood disorders  [R]
10. Prevention of suicide and suicidal behaviour in adolescents  [P]
11. Psychosocial interventions for the secondary prevention of mental health problems in people who have sustained a traumatic physical injury  [P]
12. Return to work interventions for adjustment disorders  [P]
13. Shared decision making interventions for people with mental health conditions  [R]
14. Short-term psychodynamic psychotherapies for common mental disorders  [R]  [S]

Back to Top

1. Antidepressants and benzodiazepines for major depression  [R]
2. Low dosage tricyclic antidepressants for depression  [R]  [S]
3. Second-generation antipsychotic drugs for major depressive disorder  [P]

1. Drugs versus placebo for dysthymia  [R]
2. Pharmacotherapy for dysthymia  [R]  [S]

1. Active placebos versus antidepressants for depression  [R]  [S]
2. Acupuncture for depression  [R]
3. Alprazolam for depression  [P]
4. Amitriptyline for depression  [R]  [S]
5. Antidepressant prevention of postnatal depression  [R]
6. Antidepressants for anorexia nervosa  [R]  [S]  
7. Antidepressants for depressed elderly  [R]  [S]
8. Antidepressants for depression in adults with HIV infection  [P]
9. Antidepressants for depression in physically ill people  [R]
10. Antidepressants in the treatment of depression in dementia  [R]  [S] 
11. Antidepressants versus placebo for depression in primary care  [R]
12. Antidepressants versus placebo for the depressed elderly  [R]
13. Antidepressant treatment for post-natal depression  [R]  [S]
14. Electroconvulsive therapy for the depressed elderly  [R]  [S]
15. Escitalopram versus other antidepressive agents for depression  [R]
16. Exercise for depression  [R]
17. Exercise for older depressed people  [P]
18. Fluvoxamine versus other anti-depressive agents for depression  [R]
19. Fluoxetine versus other types of pharmacotherapy for depression  [R]  [S]
20. Folate for depressive disorders  [R]  [S]
21. Inositol for depressive disorders  [R] [S]
22. Interventions for helping people recognise early signs of recurrence in depression  [P]
23. Interventions for preventing depression after stroke  [R]  [S]
24. Interventions for preventing relapse and recurrence after the first episode of a depressive disorder in young people  [P]
25. Interventions for treating depression after stroke  [R]
26. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression  [R]
27. Interventions to improve occupational health in depressed people  [R]
28. Light therapy for non-seasonal depression  [R]  [S]
29. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder  [R]  [S]
30. Marital therapy for depression  [R]  [S]
31. Milnacipran versus other antidepressive agents for depression  [R]
32. Music therapy for depression  [R]
33. Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders  [P]
34. Pharmacological treatment of depression in patients with a primary brain tumour  [R]
35. Pharmacological treatment for psychotic depression  [R]  [S]
36. Pharmacologic treatment of depression in multiple sclerosis  [P]
37. Psychological and/or educational interventions for the prevention of depression in children and adolescents  [R]  [S]
38. Psychological and pharmacological interventions for depression in patients with coronary artery disease  [P]
39. Psychological and pharmacological interventions for depression in patients with diabetes mellitus  [P]
40. Psychological interventions for depression in adolescent and adult congenital heart disease  [R]
41. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents  [P]
42. Psychosocial and psychological interventions for preventing postpartum depression  [R]  [S]
43. Psychosocial interventions by general practitioners  [R]  [S]
44. Psychosocial interventions for prevention of depression in older people  [P]
45. Psychosocial interventions for prevention of psychological disorders in law enforcement officers  [R]
46. Psychostimulants for depression  [R]
47. Psychotherapeutic treatments for older depressed people  [R]
48. Psychotherapy for depression among incurable cancer patients  [R]
49. Psychotherapy for depression in children and adolescents  [P]
50. Reboxetine versus other antidepressive agents for depression  [P]
51. Relaxation for depression  [R]
52. Screening and case finding instruments for depression  [R]  [S]
53. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents  [R] [s]
54. Sertraline versus other antidepressive agents for depression  [R]
55. St John's wort for major depression  [R]  [S]
56. Tai Chi for depression  [P]
57. Transcranial magnetic stimulation for treating depression  [R]
58. Tricyclic drugs for depression in children and adolescents  [R]
59. Tryptophan and 5-Hydroxytryptophan for depression  [R]

Back to Top

1. Aripiprazole alone or in combination for acute mania  [P]
2. Family interventions for bipolar disorder  [R]
3. Haloperidol alone or in combination for acute mania  [R]
4. Interventions for helping people recognise early signs of recurrence in bipolar disorder  [R]
5. Lithium for acute mania  [P]
6. Olanzapine alone or in combination for acute mana  [R] [S]
7. Olanzapine in long-term treatment for bipolar disorder  [R]
8. Omega-3 fatty acids for bipolar disorder  [R]
9. Oxcarbazepine in the maintenance treatment of bipolar disorder  [R]
10. Oxcarbazepine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability  [P]
11. Risperidone alone or in combination for acute mania  [R]
12. Risperidone in long-term treatment for bipolar disorder  [R]  [S]
13. Tiagabine in the maintenance treatment of bipolar disorders  [R]  [S]
14. Tiagabane in the treatment of acute affective episodes in bipolar disorder  [R]  [S]
15. Topiramate for acute affective episodes in bipolar disorder  [R]  [S]
16. Valproate for acute mood episodes in bipolar disorder  [R]  [S]
17. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder  [R]
18. Ziprasidone alone or in combination for acute mania  [P]

1. No reviews currently available for this topic

Back to Top

1. Cognitive behavioural therapy for anxiety disorders in later life  [P]
2. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia  [R]
3. Combined psychotherapy plus benzodiazepines for panic disorder  [R]

Panic disorder with agoraphobia

1. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia  [R]
2. Combined psychotherapy plus benzodiazepines for panic disorder  [R]

Agoraphobia without a history of panic disorder

1. No reviews currently available for this topic

Specific phobia

1. No reviews currently available for this topic

Social phobia

1. Pharmacotherapy for social anxiety disorder  [R]

Obsessive compulsive disorder

1. Behavioural and cognitive-behavioural therapy for obsessive-compulsive disorder in children and adolescents  [R]
2. Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders  [P]
3. Pharmacological interventions for obsessive-compulsive personality disorder  [P]
4. Psychological interventions for obsessive-compulsive personality disorder  [P]
5. Psychological therapies versus pharmacotherapy for obsessive compulsive disorder  [P]
6. Second-generation antipsychotic drugs for obsessive compulsive disorder  [P]
7. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)  [R]
8. Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder  [R]  [S]

Traumatic stress disorder

1. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)  [R]
2. Early psychological interventions to treat acute traumatic stress symptoms  [R]
3. Multiple session early psychological interventions for the prevention of post-traumatic stress disorder  [R]
4. Pharmacotherapy for post traumatic stress disorder (PTSD)  [R]  [S]
5. Pharmacotherapy for prevention of post-traumatic stress disorder  [P]
6. Psychological debriefing for preventing post traumatic stress disorder (PTSD)  [R]
7. Psychological therapies for the prevention and treatment of post-traumatic stress disorder in children and adolescents  [P]
8. Psychological treatment of post-traumatic stress disorder (PTSD)  [R]  [S]
9. Sports and games for post-traumatic stress disorder (PTSD)  [R]
10. Transcranial magnetic stimulation for post-traumatic stress disorder  [P]

Acute stress disorder

1. No reviews currently available for this topic

Generalised anxiety

1. Antidepressants for generalized anxiety disorder  [R]  [S]
2. Azapirones for generalized anxiety disorder  [R]
3. Hydroxyzine for generalised anxiety disorder  [P]
4. Psychological therapies for generalised anxiety disorder  [R]

Anxiety disorder due to general medical condition

1. Drug therapy for anxiety in palliative care  [R]  [S] 
2. Pharmacological interventions for the treatment of anxiety and panic in chronic obstructive pulmonary disease  [P]
3. Premedication for anxiety in adult day surgery  [R]

Substance induced anxiety disorder

1. No reviews currently available for this topic

Anxiety disorder not otherwise specified

1. Augmentation of psychotherapy with d-cycloserine for anxiety disorders  [P]

2. Benzodiazepines for delirium  [P]

3. Cognitive-behavioural interventions for children who have been sexually abused  [R]  [S]
4. Duloxetine for Generalized Anxiety Disorder (GAD)  [P]
5. Kava extract versus placebo for treating anxiety  [R]  [S]
6. Massage and touch for dementia  [R]  [S]
7. Meditation therapy for anxiety disorders  [R]
8. Memantine for dementia  [R]  [S]
9. Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders  [P]

10. Newer anticonvulsants in the treatment of anxiety disorders  [P]

11. Paraprofessionals for depressive and anxiety disorders  [R]  [S]
12. Passiflora for anxiety disorder  [R]

13. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders  [R]

14. Pharmacotherapy for anxiety disorders in children and adolescents  [R]

15. Pharmacotherapy for anxiety disorders in later life  [P]

16. Psychosocial interventions for prevention of psychological disorders in law enforcement officers  [P]
17. Screening and case finding instruments for depression  [R]

18. Second-generation antipsychotic drugs for anxiety disorders  [P]

19. Therapeutic touch for anxiety disorders  [R]

20. Valerian for anxiety disorder  [R]  [S]

Back to Top

1. Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality  [R]
2. Compulsory community and involuntary outpatient treatment for people with severe mental disorders  [R]

3. Containment strategies for people with serious mental illness  [R]  [S]

4. Crisis intervention for people with severe mental illnesses  [R]

5. Day hospital versus admission for acute psychiatric disorders  [R]
6. Day hospital versus outpatient care for people with schizophrenia  [R]
7. Length of hospitalisation for people with severe mental illness  [R]

8. Monetary incentives for schizophrenia  [R]

9. Open general medical wards versus specialist psychiatric units for acute psychoses   [R]
10. Outcome measures and needs assessment tools for schizophrenia and related disorders  [R]  [S]
11. Psychosocial interventions for people with both severe mental illness and substance misuse  [R]

12. Rehabilitation programmes for schizophrenia  [P]

13. Supported housing for people with severe mental disorders  [R]

14. Treatment delivery using information and communication technology for people with schizophrenia  [P]

15. Twenty-four hour care for schizophrenia  [R]

Drugs

1. Beta-blocker supplementation of standard drug treatment for schizophrenia  [R] 

Amino acids, enzymes, oils and nutritional agents

1. Glutamatergic drugs for schizophrenia  [R]  [S]
2. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]
3. Polyunsaturated fatty acid supplementation for schizophrenia  [R]  [S]
4. Vitamin E for neuroleptic-induced tardive dyskinesia  [R]

Anaesthesia-related agents / muscle relaxants

1. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Anti-convulsants / convulsants

1. Carbamazepine for schizophrenia  [R]
2. Lamotrigine for schizophrenia  [R]  [S]
3. Valproate for schizophrenia  [R]  [S]

Anti-depressants

1. Antidepressants for people with both schizophrenia and depression  [R]
2. Antidepressants for the negative symptoms of schizophrenia  [R]  [S]
3. Lithium for schizophrenia  [R]  [S]
4. Maintenance treatment with antipsychotic drugs for schizophrenia  [P]
5. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Anti-glucocorticoids

1. Antiglucocorticoid and related treatments for psychosis  [P]

Anti-movement disorders

1. Anticholinergic medication for neuroleptic-induced tardive dyskinesia  [R]
2. Anticholinergics for neuroleptic-induced acute akathisia  [R]  [S]
3. Benzodiazepines for neuroleptic-induced tardive dyskinesia  [R]  [S]
4. Calcium channel blockers for neuroleptic-induced tardive dyskinesia  [R]  [S]
5. Cholinergic medication for neuroleptic-induced tardive dyskinesia  [R]
6. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia  [R]
7. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Anti-psychotics

1. Acetylcholinesterase inhibitors for schizophrenia  [P]
2. Amisulpride for schizophrenia  [R]
3. Amisulpride versus other atypical antipsychotics for schizophrenia  [R]
4. Amphetamines for schizophrenia  [R]  [S] 
5. Antipsychotic medication for early episode schizophrenia  [P]
6. Antipsychotic medication versus placebo for people with both schizophrenia and learning disability  [R]  [S]
7. Antipsychotic drug treatment for elderly people with late-onset schizophrenia  [R]  [S]
8. Antipsychotic medication for elderly people with schizophrenia  [R]  [S]
9. Aripiprazole for schizophrenia  [R]  [S]
10. Aripiprazole versus other atypical antipsychotics for schizophrenia  [R]
11. Aripiprazole versus typical antipsychotic drugs for schizophrenia  [R]
12. 'As required' medication regimens for seriously mentally ill people in hospital  [R]
13. Atypical antipsychotics for people with both schizophrenia and depression  [R]
14. Benperidol for schizophrenia  [R]  [S]
15. Chlorpromazine dose for people with schizophrenia  [R]
16. Chlorpromazine versus placebo for schizophrenia  [R]  [S]
17. Clotiapine for acute psychotic illnesses  [R]
18. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia  [R]
19. Clozapine versus typical neuroleptic medication for schizophrenia  [R]
20. Depot bromperidol decanoate for schizophrenia  [R]  [S]
21. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders  [R]
22. Depot fluphenazine decanoate and enanthate for schizophrenia  [R]  [S]
23. Depot fluspirilene for schizophrenia  [R]
24. Depot risperidone for schizophrenia  [R]  [S]
25. Depot perphenazine decanoate and enanthate for schizophrenia  [R]  [S]
26. Depot pipotiazine palmitate and undecylenate for schizophrenia  [R]  [S]
27. Droperidol for acute psychosis  [R]
28. Haloperidol dose for the acute phase of schizophrenia  [R]
29. Haloperidol versus placebo for schizophrenia  [R]  [S]
30. Haloperidol versus chlorpromazine for schizophrenia  [R]
31. Intermittent drug techniques for schizophrenia  [P]
32. Levomepromazine for schizophrenia  [P]
33. Loxapine for schizophrenia  [R]
34. Molindone for schizophrenia and severe mental illness  [R]
35. Newer atypical antipsychotic medication versus clozapine for schizophrenia  [R]
36. New generation antipsychotics for first episode schizophrenia  [R]  [S]
37. Olanzapine for schizophrenia  [R]  [S]
38. Olanzapine depot for schizophrenia  [P]
39. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses  [R]
40. Olanzapine versus other atypical antipsychotics for schizophrenia  [R]
41. Oral paliperidone for schizophrenia  [R]
42. Pericyazine for schizophrenia  [P]
43. Pharmacological interventions for clozapine-induced hypersalivation  [R]
44. Pharmacological treatments for psychosis-related polydipsia  [R]  [S]
45. Paliperidone palmitate for schizophrenia  [P]
46. Penfluridol for schizophrenia  [R]  [S]
47. Pimozide for schizophrenia or related psychoses  [R]
48. Perazine for schizophrenia  [R]  [S]
49. Perphenazine for schizophrenia  [R]  [S]
50. Quetiapine for schizophrenia  [R]  [S]
51. Quetiapine versus other atypical antipsychotics for schizophrenia  [R]
52. Quetiapine versus typical antipsychotic medications for schizophrenia  [P]
53. Risperidone dose for schizophrenia  [R]
54. Risperidone versus olanzapine for schizophrenia  [R]  [S]
55. Risperidone versus placebo for schizophrenia  [R]
56. Risperidone versus other atypical antipsychotic medication for schizophrenia  [R]
57. Risperidone versus typical antipsychotic medication for schizophrenia  [R]  [S]
58. Sertindole for schizophrenia  [R]  [S]
59. Sulpiride for schizophrenia  [R]
60. Thioridazine for schizophrenia  [R]
61. Trifluoperazine for schizophrenia  [R]  [S]
62. Sertindole versus other atypical antipsychotics for schizophrenia  [R]
63. Sulpiride versus placebo for schizophrenia  [R]
64. Sulpiride augmentation for schizophrenia  [R]
65. Sulpiride versus other antipsychotics for schizophrenia  [P]
66. Ziprasidone for schizophrenia and severe mental illness  [R]
67. Ziprasidone versus other atypical antipsychotics for schizophrenia  [R]
68. Zotepine for schizophrenia  [R]  [S]
69. Zotepine versus other atypical antipsychotics for schizophrenia  [R]
70. Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses  [R]  [S]
71. Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses  [R]
72. Zuclopenthixol dihydrochloride for schizophrenia  [R]  [S]

Anxiolytics / hypnotics

1. Benzodiazepines for psychosis-induced aggression or agitation  [R]
2. Benzodiazepines for neuroleptic-induced acute akathisia  [R]
3. Benzodiazepines for neuroleptic-induced tardive dyskinesia  [R]  [S]
4. Benzodiazepines for schizophrenia  [R]

Central nervous system stimulants / depressants

1. Cannabis and schizophrenia  [R]
2. Nicotine for schizophrenia  [R]  [S]

Hormones

1. Estrogen for schizophrenia  [R]  [S]
2. Testosterone for schizophrenia  [R]

Parasympathomimetic / Sympathomimetic agents

1. Non-neuroleptic catecholaminergic drugs for neuroleptic-induced tardive dyskinesia  [R]

Physical treatments other than drugs

1. Acupuncture for schizophrenia  [R]
2. Ayurvedic medicine for schizophrenia  [R]
3. Chinese herbal medicine for schizophrenia  [R]  [S]
4. Electroconvulsive therapy for schizophrenia  [R]  [S]
5. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia  [R]

Therapy

1. Art therapy for schizophrenia or schizophrenia-like illnesses  [R]  [S]
2. Cognitive behaviour therapy for schizophrenia  [R]  [S]
3. Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia  [P]
4. Cognitive behaviour therapy versus standard care for schizophrenia  [P]
5. Cognitive rehabilitation for people with schizophrenia and related conditions  [R]
6. Compliance therapy for schizophrenia  [R]  [S]
7. Dance therapy for schizophrenia  [R]
8. Distraction techniques for schizophrenia  [R]  [S]
9. Drama therapy for schizophrenia or schizophrenia-like illnesses  [R]
10. Early intervention for psychosis  [R]  [S]
11. Educational games for mental health professionals  [R]
12. Exercise therapy for schizophrenia  [R]
13. Family intervention for schizophrenia  [R]  [S]
14. Hypnosis for schizophrenia  [R]  [S]
15. Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness  [R]
16. Life skills programmes for chronic mental illnesses  [R]
17. Morita therapy for schizophrenia  [R]
18. Music therapy for schizophrenia or schizophrenia-like illnesses  [R]  [S]
19. Problem solving skills for schizophrenia  [R]
20. Psychoeducation for schizophrenia  [R]
21. Supportive therapy for schizophrenia  [R]
22. Token economy for schizophrenia  [R]
23. Vocational rehabilitation for people with severe mental illness  [R]

Back to Top

1. Acupuncture for insomnia  [R]
2. Alternatives to inpatient mental health care for children and young people  [R]
3. Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses  [R]
4. Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment  [P]
5. Cognitive-behavioral treatment for antisocial behavior in youth in residential treatment  [R] 
6. Effectiveness and cost effectiveness of counselling in primary care  [R]
7. Interventions for smoking cessation and reduction in individuals with schizophrenia  [R]
8. Life skills programmes for chronic mental illnesses  [R]
9. Pharmacotherapy and psychotherapy for body dysmorphic disorder  [P]
10. Physical activity for improving cognition in older people with mild cognitive impairment  [P]
11. Physical health care monitoring for people with serious mental illness  [P]
12. Preventing occupational stress in healthcare workers  [R]
13. Problem solving treatment (PST) for emotional problems in primary care  [P]
14. Prompts to encourage appointment attendance for people with serious mental illness  [R]
15. Psychosocial and pharmacological treatments for deliberate self harm  [R]
16. Psychosocial interventions by general practitioners  [R]  [S]
17. Psychosocial interventions for conversion disorder  [R]
18. Psychosocial interventions for people with both severe mental illness and substance misuse  [R]
19. Reiki treatment for psychological symptoms  [P]
20. Strategies for managing sexual dysfunction induced by antidepressant medication  [R]  [S]
21. Subjective barriers to prevent wandering of cognitively impaired people  [R]
22. Supported employment for adults with severe mental illness  [P]
23. Supported housing for people with severe mental disorders  [R]  [S] 

Back to Top